loadpatents
Patent applications and USPTO patent grants for Moulon; Corinne.The latest application filed is for "fgfr expression and susceptibility to an fgfr inhibitor".
Patent | Date |
---|---|
Methods of cancer therapy by inhibiting fusion polypeptides comprising fibroblast growth factor receptor 2 (FGFR2) and vinculin (VCL) Grant 10,703,798 - Tanaka , et al. | 2020-07-07 |
Fgfr Expression And Susceptibility To An Fgfr Inhibitor App 20180223371 - VASLIN-CHESSEX; Anne ;   et al. | 2018-08-09 |
Fgfr Fusions App 20170107271 - TANAKA; Hiroaki ;   et al. | 2017-04-20 |
Synthetic chemokines labeled at selected positions App 20040138422 - Demotz, Stephane ;   et al. | 2004-07-15 |
Pharmaceutical composition for preventing or treating a disease associated with an excess of IL-12-production App 20020119967 - Moulon, Corinne ;   et al. | 2002-08-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.